1. Home
  2. Labeler Index
  3. Heron Therapeutics, Inc.
  4. 47426-401
  5. NDC Package Code: 47426-401-10 Aponvie

NDC Package 47426-401-10 Aponvie

Aprepitant Emulsion Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
47426-401-10
Package Description:
10 VIAL, GLASS in 1 CARTON / 4.4 mL in 1 VIAL, GLASS (47426-401-01)
Product Code:
47426-401
Proprietary Name:
Aponvie
Non-Proprietary Name:
Aprepitant
Substance Name:
Aprepitant
Usage Information:
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
11-Digit NDC Billing Format:
47426040110
Billing Unit:
C112160
NDC to RxNorm Crosswalk:
  • RxCUI: 2631783 - aprepitant 32 MG in 4.4 ML Injection
  • RxCUI: 2631783 - 4.4 ML aprepitant 7.2 MG/ML Injection
  • RxCUI: 2631783 - aprepitant 32 MG per 4.4 ML Injection
  • RxCUI: 2631788 - APONVIE 32 MG in 4.4 ML Injection
  • RxCUI: 2631788 - 4.4 ML aprepitant 7.2 MG/ML Injection [Aponvie]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heron Therapeutics, Inc.
    Dosage Form:
    Emulsion - A dosage form consisting of a two-phase system comprised of at least two immiscible liquids1, one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. (Note: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment.)
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • APREPITANT 32 mg/4.4mL
    • Pharmacologic Class(es):
  • Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
  • Neurokinin 1 Antagonists - [MoA] (Mechanism of Action)
  • Substance P/Neurokinin-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA216457
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-06-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 47426-401-10 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    47426040110C9145Inj, aponvie, 1 mg1 MG4.41032320

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 47426-401-10?

    The NDC Packaged Code 47426-401-10 is assigned to a package of 10 vial, glass in 1 carton / 4.4 ml in 1 vial, glass (47426-401-01) of Aponvie, a human prescription drug labeled by Heron Therapeutics, Inc.. The product's dosage form is emulsion and is administered via intravenous form.

    Is NDC 47426-401 included in the NDC Directory?

    Yes, Aponvie with product code 47426-401 is active and included in the NDC Directory. The product was first marketed by Heron Therapeutics, Inc. on March 06, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 47426-401-10?

    The contents of this package are billed C112160

    What is the 11-digit format for NDC 47426-401-10?

    The 11-digit format is 47426040110. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-247426-401-105-4-247426-0401-10